| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3907206
Max Phase: Preclinical
Molecular Formula: C17H15BrN2
Molecular Weight: 327.23
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Brc1cccc(C2NCCc3c2[nH]c2ccccc32)c1
Standard InChI: InChI=1S/C17H15BrN2/c18-12-5-3-4-11(10-12)16-17-14(8-9-19-16)13-6-1-2-7-15(13)20-17/h1-7,10,16,19-20H,8-9H2
Standard InChI Key: JLLIXGNATVZMLM-UHFFFAOYSA-N
Associated Targets(non-human)
Sodium/iodide cotransporter 83 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 327.23 | Molecular Weight (Monoisotopic): 326.0419 | AlogP: 4.17 | #Rotatable Bonds: 1 |
| Polar Surface Area: 27.82 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 8.31 | CX LogP: 4.14 | CX LogD: 3.18 |
| Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.69 | Np Likeness Score: 0.05 |
References
| 1. (2014) Heterocyclic compounds as inhibitors of the sodium iodide symporter, |
Source
Source(1):